Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Projected Compound Annual Growth Rate (CAGR) of the Gastrointestinal Pathogen Testing Market from 2025 to 2034, and What Factors Influence It?
There has been a consistent increase in the size of the gastrointestinal pathogen testing market in the past few years. It is projected to rise from $4.05 billion in 2024 to $4.24 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. The increase in the market’s size over the historic period can be traced back to various factors. These include rising occurrence of gastrointestinal infections, expanding awareness about illnesses stemming from contaminated food, globalization resulting in increased travel-related infections, regulatory measures geared towards food safety, higher healthcare spending, as well as a growing demand for rapid and accurate diagnostic solutions.
The market for testing gastrointestinal pathogens is anticipated to experience sustained growth in the forthcoming years, with an expected value of $5.01 billion at a compound annual growth rate (CAGR) of 4.3% by 2029. This expected growth in the forecast timeframe can be due to factors such as rising numbers of gastrointestinal infections worldwide, increased consciousness regarding early diagnosis and treatment, developing healthcare structures in emerging economies, elevated demand for point-of-care testing solutions, increased emphasis on food safety rules, and ongoing research and development endeavors. Key trends during the predicted period encompass quick testing techniques, enhanced acceptance of molecular diagnostic methods, extension of point-of-care testing in non-conventional healthcare environments, advancements in automation and robotics for efficient testing procedures, the introduction of innovative biomarkers for better pathogen detection, and the incorporation of artificial intelligence and machine learning algorithms.
Which Drivers Are Expected to Have the Greatest Impact on the Gastrointestinal Pathogen Testing Market’s Growth?
An upward trend in foodborne illnesses is projected to drive the expansion of the gastrointestinal pathogen testing market. Foodborne ailments result from ingestion of food or drink contaminated with harmful microorganisms, toxins, or chemicals. Some such diseases are listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The escalation of foodborne outbreaks can be attributed to alterations in food production, distribution, and consumption methods, insufficient food safety precautions, and the influence of climate change on food production. Gastrointestinal testing plays a crucial role in pinpointing the specific pathogens responsible for foodborne diseases, thus aiding healthcare practitioners in diagnosing the source of gastrointestinal symptoms, determining suitable treatment, tracking disease spread, and executing measures to mitigate the proliferation of foodborne diseases. For instance, the UK Health Security Agency noted in February 2024 that England and Wales recorded 167 listeriosis cases in 2022, a slight increase from 160 cases in 2021. Thus, the surge in foodborne disease incidents is fuelling the growth of the gastrointestinal pathogen testing market.
Request Your Free Gastrointestinal Pathogen Testing Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp
Who Are the Leading Players Fueling Growth in the Gastrointestinal Pathogen Testing Market?
Major companies operating in the gastrointestinal pathogen testing market are:
• Microsoft Corporation_x000D_
• Amazon Web Services Inc._x000D_
• Intel Corporation_x000D_
• Qualcomm Incorporated_x000D_
• NVIDIA Corporation_x000D_
What Are the Emerging Trends Shaping the Future of the Gastrointestinal Pathogen Testing Market?
Leading corporations in the gastrointestinal pathogen testing market are concentrating on inventing innovative solutions like metagenomic diagnostic tests. This advanced technology helps improve effectiveness and the speed of identifying gastrointestinal pathogens. Such tests are used to examine the genetic materials of microorganisms that exist in various samples, including stool or blood. In 2024, Microba Life Sciences, an Australian biotech company, presented MetaPanel, a metagenomic diagnostic test created to identify a broad span of gastrointestinal pathogens with peerless precision. The MetaPanel test can identify up to 175 pathogen targets in one single test, providing healthcare workers with an inclusive solution for diagnosing infections that are both typical and difficult to identify. Using next-gen sequencing technology, this test can scrutinize a wide variety of genetic materials present in stool samples, making it possible to detect multiple potential pathogens, even those that are not frequently tested in traditional gastrointestinal panels.
Pre-order Your Report for Quick and Easy Delivery!
Which Primary Segments of the Gastrointestinal Pathogen Testing Market Are Driving Growth and Industry Transformations?
The gastrointestinal pathogen testing market covered in this report is segmented –
1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users
Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens
Which Regions Are Driving Growth in the Gastrointestinal Pathogen Testing Market?
North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Defines the Scope of the Gastrointestinal Pathogen Testing Market?
Gastrointestinal pathogen testing refers to the process of diagnosing infections and diseases resulting from different pathogens impacting the digestive tract, comprising the stomach and intestines. It encompasses examining specimens, such as stool or blood, to pinpoint the particular pathogens causing gastrointestinal symptoms, facilitating the precise diagnosis and treatment of gastrointestinal disorders.
Browse Through More Similar Reports By The Business Research Company:
Food Pathogen Safety Testing Equipment And Supplies Global Market Report 2024
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024
Gastrointestinal Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
